German China

Potential Medicine Get Ready for More Effective Cancer Drugs with Less Side Effects

Source: Press release University of Bristol 2 min Reading Time

Related Vendor

A chemistry breakthrough has been achieved by chemists wherein they can make substitutes of the Tamoxifen drug which is used to prevent breast cancer in women and men. The new drug alternatives have the potential to be more effective and also have less side effects.

The research found a new mechanism associated with the chemical reaction which enables the shape of the compound to be flipped from being right-handed to left-handed by simply adding a common agent in the chemical reaction.(Source:  Pixabay)
The research found a new mechanism associated with the chemical reaction which enables the shape of the compound to be flipped from being right-handed to left-handed by simply adding a common agent in the chemical reaction.
(Source: Pixabay)

Bristol/UK – The research, led by the University of Bristol and published recently in the journal Nature, found a new mechanism associated with the chemical reaction which enables the shape of the compound to be flipped from being right-handed to left-handed by simply adding a common agent in the chemical reaction.

Study lead author Varinder Aggarwal, Professor of Synthetic Chemistry at the University of Bristol, said: “The findings change our understanding of the fundamental chemistry of this group of organic molecules. It presents exciting implications because the science allows us to make alternatives of the drug Tamoxifen, with potentially greater potency and less unwanted side effects.”

While most alkenes are easy to prepare, a specific type with four different parts – called tetrasubstituted alkenes – are much more challenging but used to make cancer-fighting medicines and natural products like essential oils. So, the research team aimed to find a more efficient method of making tetrasubstituted alkenes, including Tamoxifen, which allows them to be easily manipulated and adapted into different forms.

The new method offers a highly versatile solution to building complex tetrasubstituted alkenes from simple building blocks.

Prof Aggarwal explained: “Our original design plan used organic boronic esters as the key ingredient but that resulted in unstable intermediates, so didn’t work. “We then tried a less common form of boron containing molecules, namely boranes and that’s when the clever molecular gymnastics became possible. This new boron system enabled the installation of different groups on the alkene in a controlled manner from very simple building blocks, like Lego.

“It’s so exciting because it holds the key to finding even better drug molecules – like alternatives to Tamoxifen – with more of the properties you want and less of what is undesirable, such as side effects.” The scientists enlisted the help of computational chemists at Colorado State University to map exactly what was happening. That led to the full extent of their discovery being uncovered.

Co-author Robert Paton, Professor in Chemistry at Colorado State University, said: “The mechanism showed that by just changing the reaction conditions through adding an agent, the geometry of the alkene can switch direction from left to right. This was surprising and hadn’t been seen before.”

In addition to drug molecules like Tamoxifen, the researchers also worked with natural products such as γ-bisabolene, a fragrant compound found in essential oils, to demonstrate the broad applications of their breakthrough. Prof Aggarwal added: “Now we have struck upon an effective, flexible methodology, it allows us to swap in other molecules so the potential here is wide-reaching for both drug discovery and materials science.”

The research was funded by the UK Research and Innovation (UKRI) Engineering and Physical Sciences Research Council (EPSRC).

Paper: ‘Boron-Mediated Modular Assembly of Tetrasubstituted Alkenes’ by Varinder Aggarwal et al in Nature.

(ID:50476231)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent